Glycyrol Alleviates Acute Kidney Injury by Inhibiting Ferroptsis

Acute kidney injury (AKI) is a common clinical problem with high morbidity and mortality. The discovery of ferroptosis has provided novel insights into the mechanisms underlying AKI and paves the way for developing ferroptosis-based approaches to treat AKI. Glycyrol (GC) is a representative coumarin...

Full description

Bibliographic Details
Main Authors: Lixing Cao, Kai Han, Lihong Fan, Chong Zhao, Shutao Yin, Hongbo Hu
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/25/5/2458
_version_ 1797264520995930112
author Lixing Cao
Kai Han
Lihong Fan
Chong Zhao
Shutao Yin
Hongbo Hu
author_facet Lixing Cao
Kai Han
Lihong Fan
Chong Zhao
Shutao Yin
Hongbo Hu
author_sort Lixing Cao
collection DOAJ
description Acute kidney injury (AKI) is a common clinical problem with high morbidity and mortality. The discovery of ferroptosis has provided novel insights into the mechanisms underlying AKI and paves the way for developing ferroptosis-based approaches to treat AKI. Glycyrol (GC) is a representative coumarin compound isolated from licorice that demonstrates various pharmacological activities. However, its potential for a protective effect against kidney injury remains unknown. We hypothesized that GC might be able to protect against AKI via suppression of ferroptosis. This hypothesis was tested in a cell-culture model of RSL3-induced nephrocyte ferroptosis and a mouse model of folic acid-induced AKI. The results showed that GC exerted a significant protective effect against nephrocyte ferroptosis in vitro and was effective against folic acid-induced AKI in vivo, where it was mechanistically associated with suppressing HO-1-mediated heme degradation. Collectively, the findings of the present study support the hypothesis that GC holds considerable potential to be developed as a novel agent for treating ferroptosis-related AKI.
first_indexed 2024-04-25T00:30:13Z
format Article
id doaj.art-8bc8261257174fbfa012427ff452fedf
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-04-25T00:30:13Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-8bc8261257174fbfa012427ff452fedf2024-03-12T16:45:02ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672024-02-01255245810.3390/ijms25052458Glycyrol Alleviates Acute Kidney Injury by Inhibiting FerroptsisLixing Cao0Kai Han1Lihong Fan2Chong Zhao3Shutao Yin4Hongbo Hu5College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, ChinaCollege of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, ChinaCollege of Veterinary Medicine, China Agricultural University, No. 2 Yuanmingyuan West Road, Haidian District, Beijing 100193, ChinaCollege of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, ChinaCollege of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, ChinaCollege of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, ChinaAcute kidney injury (AKI) is a common clinical problem with high morbidity and mortality. The discovery of ferroptosis has provided novel insights into the mechanisms underlying AKI and paves the way for developing ferroptosis-based approaches to treat AKI. Glycyrol (GC) is a representative coumarin compound isolated from licorice that demonstrates various pharmacological activities. However, its potential for a protective effect against kidney injury remains unknown. We hypothesized that GC might be able to protect against AKI via suppression of ferroptosis. This hypothesis was tested in a cell-culture model of RSL3-induced nephrocyte ferroptosis and a mouse model of folic acid-induced AKI. The results showed that GC exerted a significant protective effect against nephrocyte ferroptosis in vitro and was effective against folic acid-induced AKI in vivo, where it was mechanistically associated with suppressing HO-1-mediated heme degradation. Collectively, the findings of the present study support the hypothesis that GC holds considerable potential to be developed as a novel agent for treating ferroptosis-related AKI.https://www.mdpi.com/1422-0067/25/5/2458glycyrolferroptosisacute kidney injuryHO-1
spellingShingle Lixing Cao
Kai Han
Lihong Fan
Chong Zhao
Shutao Yin
Hongbo Hu
Glycyrol Alleviates Acute Kidney Injury by Inhibiting Ferroptsis
International Journal of Molecular Sciences
glycyrol
ferroptosis
acute kidney injury
HO-1
title Glycyrol Alleviates Acute Kidney Injury by Inhibiting Ferroptsis
title_full Glycyrol Alleviates Acute Kidney Injury by Inhibiting Ferroptsis
title_fullStr Glycyrol Alleviates Acute Kidney Injury by Inhibiting Ferroptsis
title_full_unstemmed Glycyrol Alleviates Acute Kidney Injury by Inhibiting Ferroptsis
title_short Glycyrol Alleviates Acute Kidney Injury by Inhibiting Ferroptsis
title_sort glycyrol alleviates acute kidney injury by inhibiting ferroptsis
topic glycyrol
ferroptosis
acute kidney injury
HO-1
url https://www.mdpi.com/1422-0067/25/5/2458
work_keys_str_mv AT lixingcao glycyrolalleviatesacutekidneyinjurybyinhibitingferroptsis
AT kaihan glycyrolalleviatesacutekidneyinjurybyinhibitingferroptsis
AT lihongfan glycyrolalleviatesacutekidneyinjurybyinhibitingferroptsis
AT chongzhao glycyrolalleviatesacutekidneyinjurybyinhibitingferroptsis
AT shutaoyin glycyrolalleviatesacutekidneyinjurybyinhibitingferroptsis
AT hongbohu glycyrolalleviatesacutekidneyinjurybyinhibitingferroptsis